Edward H Cole1, Peter Nickerson, Patricia Campbell, Kathy Yetzer, Nick Lahaie, Jeffery Zaltzman, John S Gill. 1. 1 Renal Transplant Program, University Health Network, Toronto, Canada. 2 Renal Transplant Program, University of Manitoba, Winnipeg & Canadian Blood Services, Ottawa, Canada. 3 Department of Medicine and Laboratory Medicine, University of Alberta, Edmonton, Canada. 4 Canadian Blood Services, Ottawa, Canada. 5 Renal Transplant Program, St. Michael's Hospital, Toronto, Canada. 6 Division of Nephrology, University of British Columbia, St. Paul's Hospital, Vancouver, Canada. 7 Center for Health Evaluation and Outcomes Sciences, Vancouver, Canada. 8 Tuft's New England Medical Center, Boston, MA.
Abstract
BACKGROUND: Establishment of a national kidney paired donation (KPD) program represents a unique achievement in Canada's provincially organized health care system. METHODS: Key factors enabling program implementation included consultation with international experts, formation of a unique organization with a mandate to facilitate interprovincial collaboration, and the volunteer efforts of members of the Canadian transplant community to overcome a variety of logistical barriers. RESULTS: As of December 2013, the program had facilitated 240 transplantations including 10% with Calculated panel reactive antibody (cPRA) ≥97%. Unique features of the Canadian KPD program include participation of n = 55 nondirected donors, performance of only donor specific antibody negative transplants, the requirement for donor travel, and nonuse of bridge donors. CONCLUSION: The national KPD program has helped maintain the volume of living kidney donor transplants in Canada over the past 5 years and serves as a model of inter-provincial collaboration to improve the delivery of health care to Canadians.
BACKGROUND: Establishment of a national kidney paired donation (KPD) program represents a unique achievement in Canada's provincially organized health care system. METHODS: Key factors enabling program implementation included consultation with international experts, formation of a unique organization with a mandate to facilitate interprovincial collaboration, and the volunteer efforts of members of the Canadian transplant community to overcome a variety of logistical barriers. RESULTS: As of December 2013, the program had facilitated 240 transplantations including 10% with Calculated panel reactive antibody (cPRA) ≥97%. Unique features of the Canadian KPD program include participation of n = 55 nondirected donors, performance of only donor specific antibody negative transplants, the requirement for donor travel, and nonuse of bridge donors. CONCLUSION: The national KPD program has helped maintain the volume of living kidney donor transplants in Canada over the past 5 years and serves as a model of inter-provincial collaboration to improve the delivery of health care to Canadians.
Authors: Jennifer Verbesey; Alvin G Thomas; Matt Ronin; Jennifer Beaumont; Amy Waterman; Dorry L Segev; Stuart M Flechner; Matthew Cooper Journal: Am J Transplant Date: 2020-01-29 Impact factor: 8.086
Authors: Courtenay M Holscher; Kyle Jackson; Alvin G Thomas; Christine E Haugen; Sandra R DiBrito; Karina Covarrubias; Sommer E Gentry; Matthew Ronin; Amy D Waterman; Allan B Massie; Jacqueline Garonzik Wang; Dorry L Segev Journal: Am J Transplant Date: 2018-09-12 Impact factor: 8.086
Authors: Lianne Barnieh; David Collister; Braden Manns; Ngan N Lam; Soroush Shojai; Diane Lorenzetti; John S Gill; Scott Klarenbach Journal: Clin J Am Soc Nephrol Date: 2017-08-17 Impact factor: 8.237
Authors: Stuart M Flechner; Alvin G Thomas; Matthew Ronin; Jeffrey L Veale; David B Leeser; Sandip Kapur; John D Peipert; Dorry L Segev; Macey L Henderson; Ashton A Shaffer; Matthew Cooper; Garet Hil; Amy D Waterman Journal: Am J Transplant Date: 2018-04-30 Impact factor: 8.086
Authors: Rosalie A Poldervaart; Mirjam Laging; Tessa Royaards; Judith A Kal-van Gestel; Madelon van Agteren; Marry de Klerk; Willij Zuidema; Michiel G H Betjes; Joke I Roodnat Journal: J Transplant Date: 2015-09-02
Authors: K J Tinckam; R Liwski; D Pochinco; M Mousseau; A Grattan; P Nickerson; P Campbell Journal: Am J Transplant Date: 2015-06-16 Impact factor: 8.086
Authors: Eric Treat; Eric K H Chow; John D Peipert; Amy Waterman; Lorna Kwan; Allan B Massie; Alvin G Thomas; Mary Grace Bowring; David Leeser; Stuart Flechner; Marc L Melcher; Sandip Kapur; Dorry L Segev; Jeffrey Veale Journal: Am J Transplant Date: 2017-12-18 Impact factor: 9.369